A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Bosutinib D8 | CAS 2733145-45-2 - Request Quote

Picture of Bosutinib D8

Bosutinib D8

SZ CAT No:SZ-B063D01
CAS No
2733145-45-2
Mol.F.
C26H21D8Cl2N5O3
Mol.Wt.
538.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Bosutinib D8 is chemically 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl-2,2,3,3,5,5,6,6-d8)propoxy)quinoline-3-carbonitrile. Bosutinib D8 is supplied with detailed characterization data compliant with regulatory guideline. Bosutinib D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bosutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2733145-45-2

Purchase 2733145-45-2

Order 2733145-45-2

Enquire 2733145-45-2

price of 2733145-45-2

2733145-45-2 Supplier

2733145-45-2 Manufacturer

2733145-45-2 Exporter

buy high quality Bosutinib D8

Purchase Bosutinib D8

Bosutinib D8 suppliers

Bosutinib D8 manufacturers

Bosutinib D8 price

Order Bosutinib D8

Enquire Bosutinib D8

Bosutinib D8 cost

Bosutinib D8 Supplier

Bosutinib D8 Distributor

Bosutinib D8 for Method Validation

Bosutinib Reference Standard

Bosutinib D8 for ANDA Filing

Bosutinib D8 for Forced Degradation Studies

Bosutinib D8 Identification Standards

Bosutinib D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,